<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">cardiovascular</journal-id><journal-title-group><journal-title xml:lang="ru">Кардиоваскулярная терапия и профилактика</journal-title><trans-title-group xml:lang="en"><trans-title>Cardiovascular Therapy and Prevention</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1728-8800</issn><issn pub-type="epub">2619-0125</issn><publisher><publisher-name>«SILICEA-POLIGRAF» LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15829/1728-8800-2021-2993</article-id><article-id custom-type="elpub" pub-id-type="custom">cardiovascular-2993</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ИССЛЕДОВАНИЯ В КАРДИОЛОГИИ</subject></subj-group></article-categories><title-group><article-title>Взаимосвязь объема периваскулярной жировой ткани и состояния сосудистой стенки</article-title><trans-title-group xml:lang="en"><trans-title>Relationship between the volume of perivascular adipose tissue and the vascular wall lesion</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0758-5609</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Подзолков</surname><given-names>В. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Podzolkov</surname><given-names>V. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Подзолков Валерий Иванович — доктор медицинских наук, профессор, заведующий кафедрой факультетской терапии № 2, директор клиники факультетской терапии № 2</p><p>Москва</p></bio><bio xml:lang="en"><p>Moscow</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2699-1610</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Брагина</surname><given-names>А. Е.</given-names></name><name name-style="western" xml:lang="en"><surname>Bragina</surname><given-names>A. E.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Брагина Анна Евгеньевна — доктор медицинских наук, профессор кафедры факультетской терапии № 2</p><p>Москва</p></bio><bio xml:lang="en"><p>Moscow</p></bio><email xlink:type="simple">anna.bragina@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8202-4492</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Осадчий</surname><given-names>К. К.</given-names></name><name name-style="western" xml:lang="en"><surname>Osadchiy</surname><given-names>K. K.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Осадчий Константин Константинович  — кандидат медицинских наук, доцент кафедры факультетской терапии № 2</p><p>Москва</p></bio><bio xml:lang="en"><p>Moscow</p></bio><email xlink:type="simple">doctorKKO@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3461-6703</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Родионова</surname><given-names>Ю. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Rodionova</surname><given-names>Yu. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Родионова Юлия Нурисламовна  — кандидат медицинских наук, доцент кафедры факультетской терапии № 2</p><p>Москва</p></bio><bio xml:lang="en"><p>Moscow</p></bio><email xlink:type="simple">juli.n.rodionova@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7467-3318</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Джафарова</surname><given-names>З. Б.</given-names></name><name name-style="western" xml:lang="en"><surname>Jafarova</surname><given-names>Z. B.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Джафарова Зарема Болатовна — заведующая отделением функциональной диагностики Университетской клинической больницы № 4</p><p>Москва</p></bio><bio xml:lang="en"><p>Moscow</p></bio><email xlink:type="simple">zaremka1983@inbox.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2300-1914</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Лобанова</surname><given-names>М. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Lobanova</surname><given-names>M. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Лобанова Mария Вячеславовна  — кандидат медицинских наук, врач ультразвуковой диагностики Университетской клинической больницы № 4</p><p>Москва</p></bio><bio xml:lang="en"><p>Moscow</p></bio><email xlink:type="simple">lobanova_m_v@staff.sechenov.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6665-6526</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ларионова</surname><given-names>Ю. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Larionova</surname><given-names>Yu. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Ларионова Юлия Сергеевна  — студент</p><p>Москва</p></bio><bio xml:lang="en"><p>Moscow</p></bio><email xlink:type="simple">julia150499@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГАОУ ВО Первый Московский государственный медицинский университет им.И.М.Сеченова (Семеновский Университет)</institution></aff><aff xml:lang="en"><institution>I.M. Sechenov First Moscow State Medical University</institution></aff></aff-alternatives><pub-date pub-type="collection"><year>2021</year></pub-date><pub-date pub-type="epub"><day>17</day><month>11</month><year>2021</year></pub-date><volume>20</volume><issue>7</issue><fpage>2993</fpage><lpage>2993</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Подзолков В.И., Брагина А.Е., Осадчий К.К., Родионова Ю.Н., Джафарова З.Б., Лобанова М.В., Ларионова Ю.С., 2021</copyright-statement><copyright-year>2021</copyright-year><copyright-holder xml:lang="ru">Подзолков В.И., Брагина А.Е., Осадчий К.К., Родионова Ю.Н., Джафарова З.Б., Лобанова М.В., Ларионова Ю.С.</copyright-holder><copyright-holder xml:lang="en">Podzolkov V.I., Bragina A.E., Osadchiy K.K., Rodionova Y.N., Jafarova Z.B., Lobanova M.V., Larionova Y.S.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://cardiovascular.elpub.ru/jour/article/view/2993">https://cardiovascular.elpub.ru/jour/article/view/2993</self-uri><abstract><sec><title>Цель</title><p>Цель. Изучить взаимосвязь объема периваскулярной жировой ткани (ПВЖТ) и поражения сосудистой стенки.</p></sec><sec><title>Материал и  методы</title><p>Материал и  методы. В  исследование были включены 318 пациентов без сердечно-сосудистых заболеваний (средний возраст 63,5±13,7 лет). Артериальная гипертензия была выявлена у  268 (84,3%) пациентов. Всем пациентам проведена оценка антропометрических данных; показателей липидного спектра; показателей жесткости стенки артерий с  расчетом сердечно-лодыжечного индекса (CAVI  — Cardio-Ankle Vascular Index); толщины комплекса интима-медиа; сосудодвигательной функции эндотелия плечевой артерии. Проведена компьютерная томография грудной клетки с  расчетом объемов ПВЖТ и  перикардиальной жировой ткани (ПЖТ).</p></sec><sec><title>Результаты</title><p>Результаты. Объем ПВЖТ, в  среднем, составил 0,3 [0,2; 0,4] см3 . Объем ПВЖТ был статистически значимо выше у лиц с ожирением при сравнении с  пациентами с  нормальной массой тела: 0,4 [0,3; 0,5] vs 0,25 [0,2; 0,4] см3 (p=0,0007). Объем ПВЖТ был выше у лиц с  повышенным уровнем CAVI при сравнении с  пациентами с  нормальными значениями CAVI: 0,4 [0,3; 0,5] vs 0,3 [0,25; 0,3] (p=0,02). Выявлена статистически значимая корреляционная связь между объемом ПВЖТ и  индексом массы тела (r=0,27, p&lt;0,005), окружностью талии (r=0,41, p&lt;0,005), показателем CAVI (r=0,49, p&lt;0,05), нарушением эндотелий-зависимой вазодилатации плечевой артерии (r=0,38, p&lt;0,05). При проведении множественного линейного регрессионного анализа установлена значимая взаимосвязь показателя CAVI с  возрастом (β±SE 0,51±0,15 p=0,002) и  с  объемом ПВЖТ (β±SE 0,41±0,13 p=0,005).</p></sec><sec><title>Заключение</title><p>Заключение. Результаты свидетельствуют о связи ПВЖТ с висцеральной формой ожирения и  показателями жесткости сосудистой стенки.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Aim</title><p>Aim. To study the relationship between the volume of perivascular adipose tissue (PVAT) and the vascular wall lesion.</p></sec><sec><title>Material and methods</title><p>Material and methods. The study included 318 patients without cardiovascular disease (mean age, 63,5±13,7 years). Hypertension was detected in 268 (84,3%) patients. All patients underwent assessment of anthropometric characteristics, lipid profile, arterial wall stiffness with the estimation of cardio-ankle vascular index, intima-media thickness, brachial artery endothelial vasomotor function. Chest computed tomography was performed with the estimation of the volumes of PVAT and pericardial adipose tissue (PAT).</p></sec><sec><title>Results</title><p>Results. The volume of PVAT, on average, was 0,3 [0,2; 0,4] cm3 . The VAT volume was significantly higher in obese individuals when compared with patients with normal body weight: 0,4 [0,3; 0,5] vs 0,25 [0,2; 0,4] cm3 (p=0,0007). The VAT volume was higher in individuals with an increased CAVI level when compared with patients with normal CAVI values: 0,4 [0,3; 0,5] vs 0,3 [0,25; 0,3] (p=0,02). A significant correlation was found between the VAT volume and body mass index (r=0,27, p&lt;0,005), waist circumference (r=0,41, p&lt;0,005), CAVI (r=0,49, p&lt;0,05), impaired endothelium-dependent brachial artery vasodilation (r=0,38, p&lt;0,05). When performing multiple linear regression, a significant relationship of CAVI was found with age (β±SE, 0,51±0,15; p=0,002) and volume of PVAT (β±SE, 0,41±0,13; p=0,005).</p></sec><sec><title>Conclusion</title><p>Conclusion. The results indicate the relationship of PVAT with visceral obesity and vascular wall stiffness parameters.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>сердечно-сосудистые заболевания</kwd><kwd>периваскулярная жировая ткань</kwd><kwd>жесткость сосудистой стенки</kwd><kwd>синдром раннего сосудистого старения</kwd><kwd>артериальная гипертензия</kwd><kwd>перикардиальная жировая ткань</kwd></kwd-group><kwd-group xml:lang="en"><kwd>cardiovascular diseases</kwd><kwd>perivascular adipose tissue</kwd><kwd>vas - cular wall stiffness</kwd><kwd>early vascular aging syndrome</kwd><kwd>arterial hypertension</kwd><kwd>pericardial adipose tissue</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Nilsson PM, Lurbe E, Laurent S. The early life origins of vascular ageing and cardiovascular risk: the EVA syndrome (review). J Hypertens. 2008;26:1049-57. doi:10.1097/HJH.0b013e3282f82c3e.</mixed-citation><mixed-citation xml:lang="en">Nilsson PM, Lurbe E, Laurent S. The early life origins of vascular ageing and cardiovascular risk: the EVA syndrome (review). J Hypertens. 2008;26:1049-57. doi:10.1097/HJH.0b013e3282f82c3e.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Laurent S, Boutouyrie P. Arterial Stiffness and Hypertension in the Elderly. Front Cardiovasc Med. 2020;7:544302. doi:10.3389/fcvm.2020.544302.</mixed-citation><mixed-citation xml:lang="en">Laurent S, Boutouyrie P. Arterial Stiffness and Hypertension in the Elderly. Front Cardiovasc Med. 2020;7:544302. doi:10.3389/fcvm.2020.544302.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Nilsson PM, Olsen MH, Laurent S. Early Vascular Aging (EVA): New Directions in Cardiovascular Protection. Amsterdam: ElsevierInc. 2015. 363р. ISBN: 9780128013878.</mixed-citation><mixed-citation xml:lang="en">Nilsson PM, Olsen MH, Laurent S. Early Vascular Aging (EVA): New Directions in Cardiovascular Protection. Amsterdam: ElsevierInc. 2015. 363р. ISBN: 9780128013878.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Nilsson PM, Boutouyrie P, Cunha P, et al. Early vascular ageing in translation: from laboratory investigations to clinical applications in cardiovascular prevention. J Hypertens. 2013;31(8):1517-26. doi:10.1097/HJH.0b013e328361e4bd.</mixed-citation><mixed-citation xml:lang="en">Nilsson PM, Boutouyrie P, Cunha P, et al. Early vascular ageing in translation: from laboratory investigations to clinical applications in cardiovascular prevention. J Hypertens. 2013;31(8):1517-26. doi:10.1097/HJH.0b013e328361e4bd.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Jiang L, Wang M, Zhang J, et al. Increased aortic calpain-1 activity mediates age associated angiotensin II signaling of vascular smooth muscle cells. PLoS ONE. 2008;3(5):e2231. doi:10.1371/journal.pone.0002231.</mixed-citation><mixed-citation xml:lang="en">Jiang L, Wang M, Zhang J, et al. Increased aortic calpain-1 activity mediates age associated angiotensin II signaling of vascular smooth muscle cells. PLoS ONE. 2008;3(5):e2231. doi:10.1371/journal.pone.0002231.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Liao D, Arnett DK, Tyroler HA, et al. Arterial Stiffness and the Development of Hypertension: The ARIC Study. Hypertension. 1999;34(2):201-6. doi:10.1161/01.hyp.34.2.201.</mixed-citation><mixed-citation xml:lang="en">Liao D, Arnett DK, Tyroler HA, et al. Arterial Stiffness and the Development of Hypertension: The ARIC Study. Hypertension. 1999;34(2):201-6. doi:10.1161/01.hyp.34.2.201.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Vlachopoulos C, Aznaouridis К, Stefanadis С. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. JACC. 2010;55:1318-27. doi:10.1016/j.jacc.2009.10.061.</mixed-citation><mixed-citation xml:lang="en">Vlachopoulos C, Aznaouridis К, Stefanadis С. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. JACC. 2010;55:1318-27. doi:10.1016/j.jacc.2009.10.061.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH). Eur Heart J. 2018;39:3021-104. doi:10.1093/eurheartj/ehy339.</mixed-citation><mixed-citation xml:lang="en">Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH). Eur Heart J. 2018;39:3021-104. doi:10.1093/eurheartj/ehy339.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Endes S, Caviezel S, Schaffner E, et al. Associations of novel and traditional vascular biomarkers of arterial stiffness: results of the SAPALDIA 3 cohort study. PLOSone. 2016;11 (9):e0163844. doi:10.1371/journal.pone.0163844.</mixed-citation><mixed-citation xml:lang="en">Endes S, Caviezel S, Schaffner E, et al. Associations of novel and traditional vascular biomarkers of arterial stiffness: results of the SAPALDIA 3 cohort study. PLOSone. 2016;11 (9):e0163844. doi:10.1371/journal.pone.0163844.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Милягин В.А., Милягина И.В., Пурыгина М. А. Метод объемной сфигмографии на аппарате VaSera VS-1500N: методические рекомендации. Смоленск: СГМА; 2014.</mixed-citation><mixed-citation xml:lang="en">Milyagin VA, Milyagina IV, Purygina MA. Volumetric sphygmography method with VaSera VS-1500N: guidelines. Smolensk: SGMA; 2014. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Orr J, Gentile C, Davy B, et al. Large artery stiffening with weight gain inhumans. Role of visceral fat accumulation. Hyper tension. 2008;51:1519-24. doi:10.1161/HYPERTENSIONAHA.108.112946.</mixed-citation><mixed-citation xml:lang="en">Orr J, Gentile C, Davy B, et al. Large artery stiffening with weight gain inhumans. Role of visceral fat accumulation. Hyper tension. 2008;51:1519-24. doi:10.1161/HYPERTENSIONAHA.108.112946.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Ferreira I, Snijder MB, Twisk JWR, et al. Central fat mass versus peripheral fat and lean mass: opposite (adverse versus favorable) associations with arterial stiffness? The Amsterdam Growth and health longitudinal study. J Clin Endocrinol Metab. 2004;89:2632-39. doi:10.1210/jc.2003-031619.</mixed-citation><mixed-citation xml:lang="en">Ferreira I, Snijder MB, Twisk JWR, et al. Central fat mass versus peripheral fat and lean mass: opposite (adverse versus favorable) associations with arterial stiffness? The Amsterdam Growth and health longitudinal study. J Clin Endocrinol Metab. 2004;89:2632-39. doi:10.1210/jc.2003-031619.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Xia N, Li H. The role of perivascular adipose tissue in obesityinduced vascular dysfunction. Br J Pharmacol. 2017;174(20): 3425-42. doi:10.1111/bph.13650.</mixed-citation><mixed-citation xml:lang="en">Xia N, Li H. The role of perivascular adipose tissue in obesityinduced vascular dysfunction. Br J Pharmacol. 2017;174(20): 3425-42. doi:10.1111/bph.13650.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Gil-Ortega M, Condezo-Hoyos L, García-Prieto CF, et al. Imbalance between pro and anti-oxidant mechanisms in perivascular adipose tissue aggravates long-term high-fat dietderived endothelial dysfunction. PLoS ONE. 2014;9(4):e95312. doi:10.1371/journal.pone.0095312.</mixed-citation><mixed-citation xml:lang="en">Gil-Ortega M, Condezo-Hoyos L, García-Prieto CF, et al. Imbalance between pro and anti-oxidant mechanisms in perivascular adipose tissue aggravates long-term high-fat dietderived endothelial dysfunction. PLoS ONE. 2014;9(4):e95312. doi:10.1371/journal.pone.0095312.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Oda A, Taniguchi T, Yokoyama M. Leptin stimulates rat aortic smooth muscle cell proliferation and migration. Kobe J Med Sci. 2001;47:141-50.</mixed-citation><mixed-citation xml:lang="en">Oda A, Taniguchi T, Yokoyama M. Leptin stimulates rat aortic smooth muscle cell proliferation and migration. Kobe J Med Sci. 2001;47:141-50.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Rittig K, Dolderer JH, BalletshoferB, et al. The secretion pattern of perivascular fat cells is different from that of subcutaneous and visceral fat cells. Diabetologia. 2012;55(5):1514-25. doi:10.1007/s00125-012-2481-9.</mixed-citation><mixed-citation xml:lang="en">Rittig K, Dolderer JH, BalletshoferB, et al. The secretion pattern of perivascular fat cells is different from that of subcutaneous and visceral fat cells. Diabetologia. 2012;55(5):1514-25. doi:10.1007/s00125-012-2481-9.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Диагностика, лечение, профилактика ожирения и ассоциированных с ним заболеваний. Национальные клинические рекомендации. Российское кардиологическое общество. Российское научное медицинское общество терапевтов. Антигипертензивная лига. Ассоциация клинических фармакологов. 2017:3-164. Доступно на https://scardio.ru/content/Guidelines/project/Ozhirenie_klin_rek_proekt.pdf. (10 June 2021).</mixed-citation><mixed-citation xml:lang="en">Diagnosis, treatment, prevention of obesity and associated diseases. National clinical guidelines. Russian Cardiology Society. Russian Scientific Medical Society of Therapists. Antihypertensive League. Association of Clinical Pharmacologists. 2017:3-164. (In Russ.) https://scardio.ru/content/Guidelines/project/Ozhirenie_klin_rek_proekt.pdf. (10 June 2021).</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Mach F, Baigent C, Catapano A, et al. 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardio vascular risk. Eur Heart J. 2020;41(1):111-88. doi:10.1093/eurheartj/ehz455.</mixed-citation><mixed-citation xml:lang="en">Mach F, Baigent C, Catapano A, et al. 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardio vascular risk. Eur Heart J. 2020;41(1):111-88. doi:10.1093/eurheartj/ehz455.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Celermajer DS, Sorensen KE, Gooch VM, et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet. 1992;340:1111-15.</mixed-citation><mixed-citation xml:lang="en">Celermajer DS, Sorensen KE, Gooch VM, et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet. 1992;340:1111-15.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Муромцева Г. А., Концевая А. В., Константинов В. В. и др. Распространенность факторов риска неинфекционных заболеваний в российской популяции в 2012-2013 гг. Результаты исследования ЭССЕ-РФ. Кардиоваскулярная терапия и профилактика. 2014;13(6):4- 11. doi:10.15829/1728-8800-2014-6-4-11.</mixed-citation><mixed-citation xml:lang="en">Muromtseva GA, Kontsevaya AV, Konstantinov VV, et al. The prevalence of non-infectious diseases risk factors in Russian population in 2012-2013 years. The results of ECVD-RF. Cardiovascular Therapy and Prevention. 2014;13(6):4-11. (In Russ.) doi:10.15829/1728-8800-2014-6-4-11.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Lehman SJ, Massaro JM, Schlett CL, et al. Peri-aortic fat, cardiovascular disease risk factors, and aortic calcification: the Framingham Heart Study. Atherosclerosis. 2010;210(2):656-61. doi:10.1016/j.atherosclerosis.2010.01.007.</mixed-citation><mixed-citation xml:lang="en">Lehman SJ, Massaro JM, Schlett CL, et al. Peri-aortic fat, cardiovascular disease risk factors, and aortic calcification: the Framingham Heart Study. Atherosclerosis. 2010;210(2):656-61. doi:10.1016/j.atherosclerosis.2010.01.007.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Schroeter MR, Eschholz N, Herzberg S, et al. Leptin-dependent and leptin-independent paracrine effects of perivascular adipose tissue on neointima formation. Arterioscler Thromb Vasc Biol. 2013;33:980-7. doi:10.1161/ATVBAHA.113.301393.</mixed-citation><mixed-citation xml:lang="en">Schroeter MR, Eschholz N, Herzberg S, et al. Leptin-dependent and leptin-independent paracrine effects of perivascular adipose tissue on neointima formation. Arterioscler Thromb Vasc Biol. 2013;33:980-7. doi:10.1161/ATVBAHA.113.301393.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Schnabel R, Larson MG, Dupuis J, et al. Relations of inflammatory biomarkers and common genetic variants with arterial stiffness and wave reflection. Hypertension. 2008;51(6):1651-7. doi:10.1161/HYPERTENSIONAHA.107.105668.</mixed-citation><mixed-citation xml:lang="en">Schnabel R, Larson MG, Dupuis J, et al. Relations of inflammatory biomarkers and common genetic variants with arterial stiffness and wave reflection. Hypertension. 2008;51(6):1651-7. doi:10.1161/HYPERTENSIONAHA.107.105668.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Lieb W, Larson MG, Benjamin EJ, et al. Multimarker approach to evaluate correlates of vascular stiffness: the Framingham Heart Study. Circulation. 2009;119(1):37-43. doi:10.1161/CIRCULATIONAHA.108.816108.</mixed-citation><mixed-citation xml:lang="en">Lieb W, Larson MG, Benjamin EJ, et al. Multimarker approach to evaluate correlates of vascular stiffness: the Framingham Heart Study. Circulation. 2009;119(1):37-43. doi:10.1161/CIRCULATIONAHA.108.816108.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Korkmaz L, Cirakoglu OF, Ağaç MT, et al. Relation of epicardial adipose tissue with arterial compliance and stiffness in patients with hypertension. Angiology. 2014;65(8):691-5. doi:10.1177/0003319713502120.</mixed-citation><mixed-citation xml:lang="en">Korkmaz L, Cirakoglu OF, Ağaç MT, et al. Relation of epicardial adipose tissue with arterial compliance and stiffness in patients with hypertension. Angiology. 2014;65(8):691-5. doi:10.1177/0003319713502120.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Kocaman SA, Baysan O, Çetin M, et al. An increase in epicardial adipose tissue is strongly associated with carotid-intima media thickness and atherosclerotic plaque, but LDL only with the plaque. Anatol J Cardiol. 2017;17(1):56-63. doi:10.14744/AnatolJCardiol.2016.6885.</mixed-citation><mixed-citation xml:lang="en">Kocaman SA, Baysan O, Çetin M, et al. An increase in epicardial adipose tissue is strongly associated with carotid-intima media thickness and atherosclerotic plaque, but LDL only with the plaque. Anatol J Cardiol. 2017;17(1):56-63. doi:10.14744/AnatolJCardiol.2016.6885.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Cabrera-Rego JO, Navarro-Despaigne D, Staroushik-Morel L, et al. Association between endothelial dysfunction, epicardial fat and subclinical atherosclerosis during menopause. Clin Investig Arterioscler. 2018;30(1):21-7. doi:10.1016/j.arteri.2017.07.006.</mixed-citation><mixed-citation xml:lang="en">Cabrera-Rego JO, Navarro-Despaigne D, Staroushik-Morel L, et al. Association between endothelial dysfunction, epicardial fat and subclinical atherosclerosis during menopause. Clin Investig Arterioscler. 2018;30(1):21-7. doi:10.1016/j.arteri.2017.07.006.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Brakenhielm E, Veitonmaki N, Cao R, et al. Adiponectin induced antiangiogenesis and antitumor activity involve caspase mediated endothelial cell apoptosis. Proc Natl Acad Sci USA. 2004;101(8):2476-81. doi:10.1073/pnas.0308671100.</mixed-citation><mixed-citation xml:lang="en">Brakenhielm E, Veitonmaki N, Cao R, et al. Adiponectin induced antiangiogenesis and antitumor activity involve caspase mediated endothelial cell apoptosis. Proc Natl Acad Sci USA. 2004;101(8):2476-81. doi:10.1073/pnas.0308671100.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Толстов С. Н., Салов И. А., Ребров А. П. Нарушения функциональной активности эндотелия и возможности их коррекции у женщин в ранней постменопаузе. Рациональная Фармакотерапия в Кардиологии. 2017;13(2):191-6. doi:10.20996/1819-6446-2017-13-2-191-196.</mixed-citation><mixed-citation xml:lang="en">Tolstov SN, Salov IA, Rebrov AP. Endothelial Dysfunctions and their Correction in Women with Early Postmenopause. Rational Pharmacotherapy in Cardiology 2017;13(2):191-6. (In Russ.) doi:10.20996/1819-6446-2017-13-2-191-196.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Pavlovska I, Kunzova S, Jakubik J, et al. Associations between high triglycerides and arterial stiffness in a populationbased sample: Kardiovize Brno 2030 study. Lipids Health Dis. 2020;19(1):170. doi:10.1186/s12944-020-01345-0.</mixed-citation><mixed-citation xml:lang="en">Pavlovska I, Kunzova S, Jakubik J, et al. Associations between high triglycerides and arterial stiffness in a populationbased sample: Kardiovize Brno 2030 study. Lipids Health Dis. 2020;19(1):170. doi:10.1186/s12944-020-01345-0.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
